Characteristics of imported Plasmodium ovale spp. and Plasmodium malariae in Hubei Province, China, 2014-2018.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
22 Jul 2020
Historique:
received: 29 03 2020
accepted: 14 07 2020
entrez: 24 7 2020
pubmed: 24 7 2020
medline: 6 3 2021
Statut: epublish

Résumé

There have been an increasing number of imported cases of malaria in Hubei Province in recent years. In particular, the number of cases of Plasmodium ovale spp. and Plasmodium malariae significantly increased, which resulted in increased risks during the malaria elimination phase. The purpose of this study was to acquire a better understanding of the epidemiological characteristics of P. ovale spp. and P. malariae imported to Hubei Province, China, so as to improve case management. Data on all malaria cases from January 2014 to December 2018 in Hubei Province were extracted from the China national diseases surveillance information system (CNDSIS). This descriptive study was conducted to analyse the prevalence trends, latency periods, interval from onset of illness to diagnosis, and misdiagnosis of cases of P. ovale spp. and P. malariae malaria. During this period, 634 imported malaria cases were reported, of which 87 P. ovale spp. (61 P. ovale curtisi and 26 P. ovale wallikeri) and 18 P. malariae cases were confirmed. The latency periods of P. ovale spp., P. malariae, Plasmodium vivax, and Plasmodium falciparum differed significantly, whereas those of P. ovale curtisi and P. ovale wallikeri were no significant difference. The proportion of correct diagnosis of P. ovale spp. and P. malariae malaria cases were 48.3% and 44.4%, respectively, in the hospital or lower-level Centers for Disease Control and Prevention (CDC). In the Provincial Reference Laboratory, the sensitivity of microscopy and rapid diagnostic tests was 94.3% and 70.1%, respectively, for detecting P. ovale spp., and 88.9% and 38.9%, respectively, for detecting P. malariae. Overall, 97.7% (85/87) of P. ovale spp. cases and 94.4% (17/18) of P. malariae cases originated from Africa. The increase in the number of imported P. ovale spp. and P. malariae cases, long latency periods, and misdiagnosis pose a challenge to this region. Therefore, more attention should be paid to surveillance of imported cases of P. ovale spp. and P. malariae infection to reduce the burden of public health and potential risk of malaria.

Sections du résumé

BACKGROUND BACKGROUND
There have been an increasing number of imported cases of malaria in Hubei Province in recent years. In particular, the number of cases of Plasmodium ovale spp. and Plasmodium malariae significantly increased, which resulted in increased risks during the malaria elimination phase. The purpose of this study was to acquire a better understanding of the epidemiological characteristics of P. ovale spp. and P. malariae imported to Hubei Province, China, so as to improve case management.
METHODS METHODS
Data on all malaria cases from January 2014 to December 2018 in Hubei Province were extracted from the China national diseases surveillance information system (CNDSIS). This descriptive study was conducted to analyse the prevalence trends, latency periods, interval from onset of illness to diagnosis, and misdiagnosis of cases of P. ovale spp. and P. malariae malaria.
RESULTS RESULTS
During this period, 634 imported malaria cases were reported, of which 87 P. ovale spp. (61 P. ovale curtisi and 26 P. ovale wallikeri) and 18 P. malariae cases were confirmed. The latency periods of P. ovale spp., P. malariae, Plasmodium vivax, and Plasmodium falciparum differed significantly, whereas those of P. ovale curtisi and P. ovale wallikeri were no significant difference. The proportion of correct diagnosis of P. ovale spp. and P. malariae malaria cases were 48.3% and 44.4%, respectively, in the hospital or lower-level Centers for Disease Control and Prevention (CDC). In the Provincial Reference Laboratory, the sensitivity of microscopy and rapid diagnostic tests was 94.3% and 70.1%, respectively, for detecting P. ovale spp., and 88.9% and 38.9%, respectively, for detecting P. malariae. Overall, 97.7% (85/87) of P. ovale spp. cases and 94.4% (17/18) of P. malariae cases originated from Africa.
CONCLUSION CONCLUSIONS
The increase in the number of imported P. ovale spp. and P. malariae cases, long latency periods, and misdiagnosis pose a challenge to this region. Therefore, more attention should be paid to surveillance of imported cases of P. ovale spp. and P. malariae infection to reduce the burden of public health and potential risk of malaria.

Identifiants

pubmed: 32698906
doi: 10.1186/s12936-020-03337-y
pii: 10.1186/s12936-020-03337-y
pmc: PMC7374957
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

264

Subventions

Organisme : the Project of Disease Control and Prevention of the Hubei Provincial Health and Family Planning Commission
ID : WJ2016J-037

Références

Clin Microbiol Rev. 2005 Jul;18(3):570-81
pubmed: 16020691
BMJ Open. 2013 May 28;3(5):
pubmed: 23793668
PLoS One. 2014 Feb 10;9(2):e87169
pubmed: 24520325
Emerg Infect Dis. 2011 Oct;17(10):1799-806
pubmed: 22000348
Clin Infect Dis. 1998 Jul;27(1):142-9
pubmed: 9675468
Int J Parasitol. 2012 Jun;42(7):693-9
pubmed: 22633951
Malar J. 2018 Feb 15;17(1):81
pubmed: 29448927
Malar J. 2014 Jun 18;13:240
pubmed: 24946685
Malar J. 2014 May 08;13:175
pubmed: 24884761
J Infect Dis. 2018 Jun 20;218(2):265-276
pubmed: 29554284
Malar J. 2016 Jan 25;15:39
pubmed: 26809828
Mol Biochem Parasitol. 1993 Apr;58(2):283-92
pubmed: 8479452
Malar J. 2018 Sep 20;17(1):334
pubmed: 30236117
Malar J. 2016 May 28;15(1):299
pubmed: 27234320
BMC Public Health. 2018 Apr 12;18(1):489
pubmed: 29650008
Trends Parasitol. 2007 Jun;23(6):278-83
pubmed: 17459775
Malar J. 2019 Apr 11;18(1):130
pubmed: 30971231
Acta Trop. 2019 Mar;191:248-251
pubmed: 30659805
PLoS Negl Trop Dis. 2019 Mar 11;13(3):e0007254
pubmed: 30856189
J Infect Dis. 2010 May 15;201(10):1544-50
pubmed: 20380562
Emerg Infect Dis. 2004 Jul;10(7):1235-40
pubmed: 15324543
Clin Microbiol Rev. 2007 Oct;20(4):579-92
pubmed: 17934075
PLoS Negl Trop Dis. 2015 Oct 20;9(10):e0004068
pubmed: 26485258
Sci Rep. 2019 Feb 18;9(1):2191
pubmed: 30778106
J Clin Microbiol. 2007 May;45(5):1624-7
pubmed: 17360843
Am J Trop Med Hyg. 2015 Aug;93(2):293-9
pubmed: 26078326
Am J Trop Med Hyg. 2006 Jul;75(1):133-8
pubmed: 16837719
J Trop Med. 2012;2012:367160
pubmed: 22529864
Emerg Infect Dis. 2014 Mar;20(3):409-16
pubmed: 24572501
Malar J. 2016 Sep 07;15:459
pubmed: 27604629
Mol Biochem Parasitol. 1993 Oct;61(2):315-20
pubmed: 8264734

Auteurs

Jing Xia (J)

Institute of Parasitic Disease Control, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.

Dongni Wu (D)

Institute of Parasitic Disease Control, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.

Lingcong Sun (L)

Institute of Parasitic Disease Control, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.

Hong Zhu (H)

Institute of Parasitic Disease Control, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.

Kaijie Li (K)

Institute of Parasitic Disease Control, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.

Juan Zhang (J)

Institute of Parasitic Disease Control, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.

Wen Lin (W)

Institute of Parasitic Disease Control, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.

Lun Wan (L)

Institute of Parasitic Disease Control, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.

Huaxun Zhang (H)

Institute of Parasitic Disease Control, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China. huaxunzhang0707@163.com.

Si Liu (S)

Institute of Parasitic Disease Control, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China. Liusi163@163.com.

Articles similaires

Humans Blindness Male Female Cross-Sectional Studies

Prevalence and implications of fragile X premutation screening in Thailand.

Areerat Hnoonual, Sunita Kaewfai, Chanin Limwongse et al.
1.00
Humans Fragile X Mental Retardation Protein Thailand Male Female
Humans Neoplasms Male Female Middle Aged
Humans Male Female Aged Middle Aged

Classifications MeSH